PremiumAC-MG-116
ACE-031
Muscle Growth & PerformancePurity: 98%
ActRIIB-Fc decoy receptor studied for myostatin and GDF-11 inhibition pathway research. Investigated in muscular dystrophy and sarcopenia preclinical models.
1
ActRIIB-Fc decoy receptor studied for myostatin and GDF-11 inhibition pathway research. Investigated in muscular dystrophy and sarcopenia preclinical models.
Related Compounds
NewAC-WL-110
5-Amino-1MQ
NNMT (nicotinamide N-methyltransferase) inhibitor studied for its effects on adipogenesis, energy expenditure, and NAD+ pathway modulation in metabolic research.
From $32.00
PremiumAC-WL-112
Adipotide (FTPP)
Prohibitin-targeting peptide studied for proapoptotic effects on white adipose tissue vasculature in preclinical obesity research models.
From $48.00
Top RatedAC-MG-101
BPC-157
Body Protection Compound studied extensively in gastric and musculoskeletal research models for its effects on growth factor expression and tissue signaling pathways.
From $45.00
PopularAC-MG-102
TB-500 (Thymosin Beta-4)
Thymic peptide researched for its role in actin regulation, cell migration, angiogenesis, and wound healing signaling in preclinical models.
$70.00